Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycyrrhetinic Acid + Dexamethasone in Newly Diagnosed ITP
NCT03998982Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Jun 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in immune thrombocytopenia (ITP) comparing Glycyrrhetinic Acid + HD-DXM with HD-DXM + Placebo (2 arms). Primary endpoint: Sustained response to ITP treatments at 3 months. Status: unknown.
02
Drugs
glycyrrhetinic acid
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT03998982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03998982.